For Alzheimer’s, amyloid plaques start in liver, not the brain

Nearly half of all Americans above the age of 85 have Alzheimer’s disease. It is estimated that by 2050 there will be 11 to 16 million people aged 65 and over with this disease. That is, unless, new methods of preventing and treating Alzheimer’s are discovered.

A recent study in the Journal of Neuroscience Research unexpectedly found that the liver is the origin of the deposition of amyloid plaques. The brain, up until now, was considered the origin.

This will likely result in having far-reaching effects on our future abilities to improve the prevention and treatment of Alzheimer’s disease.